Melanoma Survival Rates
Melanoma patients often inquire about survival rates when they are discussing their prognosis or treatment options with their physicians. Survival rates are typically broken down by stage of the cancer and reflect the percentage of people who survived at least five years after their initial diagnosis.
One of the most influential factors in improving melanoma survival rates is quality treatment and care. That’s why so many melanoma patients turn to the expert team at Moffitt Cancer Center. The following are some of the reasons why our Cutaneous Oncology Program boasts high survival rates, as well as an improved quality of life for its patients:
- On average, Moffitt's melanoma survival rates exceed 1.5 times the national average.
- We have access to the most recent, innovative treatment options, including immunotherapy and some of the world’s most promising clinical trials.
- As a National Cancer Institute-designated Comprehensive Cancer Center, Moffitt’s physicians and scientists are actively involved in the groundbreaking research of new therapies.
- Our multispecialty skin cancer team offers world-renowned expertise in melanoma and other skin cancers.
- Members of our skin cancer team across all specialties (radiology, surgery, radiation, dermatology, pathology and more) come together in a weekly tumor board, where many cases are reviewed collaboratively in order to develop the most effective, individualized treatment plan for each patient.
If you have questions about melanoma survival rates or would like to make an appointment to meet with our oncologists specializing in skin cancer, call 1-888-663-3488 or complete a new patient registration form online. We welcome patients with or without a referral.
Helpful Links: